Loading market data...
Fri, 15 May 2026
11:41:15 am
Fri, 15 May 2026
11:41:15 am
Synopsis
Lupin Limited inaugurated Atharv Ability, an advanced neuro-rehabilitation center in Delhi featuring robotics, AI-based rehabilitation systems, and multidisciplinary therapies for conditions including stroke, Parkinson’s disease, spinal injuries, and cerebral palsy, expanding specialized neurological care access in North India.
Lupin Limited has inaugurated Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center in Naraina Vihar, Delhi, marking another major expansion in the company’s specialized healthcare and rehabilitation services business.
The facility was officially launched on May 15, 2026, and becomes Lupin’s third Atharv Ability neuro-rehabilitation center after earlier launches in Mumbai in 2023 and Hyderabad in 2024.
The Delhi center has been developed to provide technology-enabled, personalized rehabilitation care for adults and children suffering from neurological disorders and disabilities. The initiative aims to improve access to advanced neuro-rehabilitation services across North India, where availability of integrated specialized rehabilitation facilities remains limited.
The center combines advanced robotics, AI-powered rehabilitation systems, multidisciplinary therapies, and personalized recovery programs focused on long-term patient outcomes.
The launch of Atharv Ability in Delhi reflects Lupin’s growing focus on rehabilitation and long-term neurological care beyond traditional pharmaceutical treatment.
The company stated that rehabilitation services remain underdeveloped in several parts of India despite increasing cases of neurological disorders, stroke recovery requirements, spinal injuries, and age-related neurological conditions.
The Delhi center aims to bridge this treatment gap by offering integrated rehabilitation programs supported by advanced technologies and specialized therapy teams.
| Parameter | Details |
|---|---|
| Facility Name | Atharv Ability |
| Company | Lupin Limited |
| Location | Naraina Vihar, Delhi |
| Launch Date | May 15, 2026 |
| Facility Type | Multidisciplinary Neuro-Rehabilitation Center |
| Existing Centers | Mumbai (2023), Hyderabad (2024) |
| Focus Area | Neurological Rehabilitation & Recovery |
The center focuses on improving patient mobility, independence, recovery outcomes, and quality of life through long-term rehabilitation support.
Atharv Ability has been designed to provide specialized rehabilitation support for a wide range of neurological disorders affecting both adults and children.
| Neurological Condition | Focus Area |
|---|---|
| Stroke | Mobility and functional recovery |
| Traumatic Brain Injury | Cognitive and physical rehabilitation |
| Spinal Cord Injury | Motor function and recovery support |
| Parkinson’s Disease | Movement and balance rehabilitation |
| Multiple Sclerosis | Neurological function management |
| Cerebral Palsy | Pediatric neuro-developmental therapy |
The company stated that the center follows an outcome-driven rehabilitation approach designed around each patient’s medical condition and recovery requirements.
One of the major highlights of the new facility is the integration of advanced rehabilitation technologies, including robotics and AI-based systems.
Lupin stated that combining technology with clinical expertise can significantly improve rehabilitation efficiency, recovery tracking, and patient engagement.
| Feature | Details |
|---|---|
| Robotic Systems | End-effector robotics for gait and hand training |
| AI-Based Systems | Balance and postural control systems |
| Neuro-Physiotherapy | Personalized physical rehabilitation |
| Occupational Therapy | Functional skill development |
| Speech & Swallowing Therapy | Communication and swallowing support |
| Additional Therapies | Aqua therapy, cognitive therapy, VR-based rehabilitation |
The facility also includes virtual reality-based rehabilitation systems designed to improve cognitive and motor recovery through interactive therapy methods.
Lupin stated that Atharv Ability follows a multidisciplinary rehabilitation model where multiple specialists collaborate to design individualized recovery plans.
The center combines:
The company believes rehabilitation outcomes improve significantly when treatment programs are customized based on patient-specific neurological conditions and recovery goals.
This approach also helps support long-term rehabilitation instead of only short-term treatment.
India has witnessed rising cases of neurological disorders due to:
However, access to integrated rehabilitation infrastructure remains limited in many regions.
Specialized neuro-rehabilitation centers are becoming increasingly important because recovery from neurological conditions often requires:
The Delhi expansion strengthens Lupin’s presence in this emerging healthcare segment.
Commenting on the launch, Rajeev Sibal, President – India Region Formulations at Lupin, stated that advances in neurological treatment are improving survival and clinical outcomes, increasing the need for long-term rehabilitation support.
According to management, Atharv Ability reflects the company’s belief that healthcare should extend beyond treatment and focus on sustained recovery, independence, and quality of life improvement.
The company also emphasized its commitment toward making specialized neuro-rehabilitation services accessible, affordable, and standardized across India.
Lupin Limited is a global pharmaceutical company headquartered in Mumbai, India, with operations across more than 100 markets worldwide.
The company operates across multiple healthcare segments including:
Lupin has a strong presence in therapy areas such as respiratory care, cardiovascular diseases, diabetes, gastrointestinal disorders, women’s health, and central nervous system treatments.
| Category | Details |
|---|---|
| Markets Served | 100+ countries |
| Manufacturing Sites | 15 |
| Research Centers | 7 |
| Global Workforce | 24,000+ employees |
The company’s healthcare ecosystem also includes Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
Lupin’s launch of the Atharv Ability neuro-rehabilitation center in Delhi marks another important step in expanding specialized rehabilitation healthcare services in India.
The center combines advanced technologies such as robotics, AI-based balance systems, virtual reality rehabilitation, and multidisciplinary therapy programs to support patients recovering from neurological disorders.
With increasing demand for long-term rehabilitation care across India, Lupin’s expansion into neuro-rehabilitation reflects growing opportunities in technology-enabled healthcare and patient recovery services.
Atharv Ability is an advanced multidisciplinary neuro-rehabilitation center launched by Lupin Limited in Naraina Vihar, Delhi, focused on specialized neurological recovery and rehabilitation care.
The Atharv Ability center in Delhi was inaugurated on May 15, 2026.
The facility provides rehabilitation services for conditions including:
The center uses:
The center offers:
No, this is Lupin’s third Atharv Ability neuro-rehabilitation center after Mumbai (2023) and Hyderabad (2024).
The facility aims to improve access to specialized neuro-rehabilitation services in North India, where integrated rehabilitation infrastructure remains limited.
Lupin aims to provide technology-enabled, personalized, affordable, and outcome-driven rehabilitation care focused on long-term recovery and improved quality of life.
Lupin Limited is headquartered in Mumbai, India.
Apart from pharmaceuticals, Lupin operates businesses including:
Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
Devyani International reported Q4 FY26 consolidated revenue growth of 18.5% to INR 14,369 million, while KFC India delivered its strongest same-store...
Vishal Mega Mart reported FY26 consolidated PAT of ₹8,392 million, up 32.8% YoY, while revenue from operations increased 20.4% to ₹1,29,063 million.
G R Infraprojects’ subsidiary Munger Link Highway Private Limited signed a ₹2,440.87 crore concession agreement with NHAI for the construction of a...
United Spirits reported FY26 standalone net profit of ₹1,830 crore on revenue of ₹27,781 crore and announced a final dividend of ₹11 per share.
NIIT reported FY26 consolidated revenue growth of 9% to Rs. 3,902 million, announced a Rs. 1 dividend, expanded AI-led skilling programs, and...
